The MedicX Fund Limited Director Declaration (4381F)
17 May 2017 - 9:35PM
UK Regulatory
TIDMMXF
RNS Number : 4381F
The MedicX Fund Limited
17 May 2017
For immediate release
17 May 2017
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Director Declaration
In accordance with Listing Rule 9.6.14, the Company wishes to
announce that it has been notified by Mrs Shelagh Mason, a
non-executive director of the Company, that on 17 May 2017, she
became a director of Global Fixed Income Realisation Limited, which
is listed on the Irish Stock Exchange and traded on the London
Stock Exchange.
End
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Chief Executive Officer
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Victoria Hayns
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", "the Fund" or "the Company", or
together with its subsidiaries, "the Group") is the specialist
primary care infrastructure investor in modern, purpose-built
primary healthcare properties in the United Kingdom and Ireland,
listed on the London Stock Exchange, with a portfolio comprising
156 properties.
The Investment Adviser to the Company is Octopus Healthcare
Adviser Ltd, which is part of the Octopus Healthcare group. Octopus
Healthcare invests in and develops properties as well as creating
partnerships to deliver innovative healthcare buildings to improve
the health, wealth and wellbeing of the UK. It currently manages
over GBP1 billion of healthcare investments across a number of
platforms, with a focus on five core areas: GP surgeries, care
homes, special education schools, retirement housing and private
hospitals. Octopus Healthcare is part of the Octopus group, a
fast-growing UK fund management business with leading positions in
several specialist sectors including healthcare property, energy,
property finance and smaller company investing. Octopus manages
GBP6 billion of funds for more than 50,000 retail and institutional
investors.
Octopus Healthcare Adviser Ltd is authorised and regulated by
the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the
contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other
website), nor the contents of any website accessible from
hyperlinks within this announcement, are incorporated into, or
forms part of, this announcement.
The Company's Legal Entity Identifier is
2138008POF35FTNFCB25.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDNEAFSXFAXXEFF
(END) Dow Jones Newswires
May 17, 2017 07:35 ET (11:35 GMT)
Medicx (LSE:MXF)
Historical Stock Chart
From Apr 2024 to May 2024
Medicx (LSE:MXF)
Historical Stock Chart
From May 2023 to May 2024